Can you protect the marijuana against Covid-19?

[wpas_products ASIN=B07S9F9SHC,B089Y7LLHD]

According to studies carried out by Canadian researchers, they believe that the medicinal plant could protect against Covid-19. The results were part of an investigation into the use of cannabis to treat cancer and Crohn’s disease.

Many pharmaceutical companies are searching for a vaccine or drug against the new SARS-CoV-2 (Covid-19). The studies currently underway have both traditional and non-traditional approaches. Examining different drugs, such as Remdesivir, which was originally developed to treat Ebola.

Marijuana helps Covid-19 symptoms

Marihuana Medicinal Curar Covid-19 Coronavirus

A report was recently published in Canada that explains that certain active ingredients in this psychoactive drug marijuana may increase the resistance of cells against the coronavirus. If proven, cannabis may act similarly to nicotine. However, this study has not yet been proven by other researchers.

“The results on COVID-19 come from our studies on arthritis, Crohn’s disease, cancer and others,” Dr. Igor Kovalchuck, professor of Biosciences at the University of Lethbridge, told DW.

There is currently a lot of interest in continuing to study cannabis, but without adequate funding and further research, knowledge about cannabinoids will be lacking, regardless of whether the research results are successful. “At least now there is broad interest,” Kovalchuck said.

While Kovalchuck and his co-authors admit that even their most effective extracts need large-scale validation, they add that cannabidiol could be a “safe supplement” for the treatment of COVID-19, in conjunction with other treatments.

At present, there is no real evidence that cannabis can protect against COVID-19. “In this case, research in Canada has just discovered a possible therapeutic ‘mechanism of action’, but it would have to be validated and tested in well-designed and robust clinical trials before any meaningful clinical conclusions could be drawn,” according to Chris Albertyn, an expert on cannabinoids and dementia, who also warns that “Given the socio-political volatility of medical cannabis use, researchers must be especially careful in disseminating their results. Adding the fear that doctors have that people will become addicted or try to treat themselves with other forms of consumption of this plant.


[wpas_products keywords=covid+supplies]

Suscribete y Recibe nuestros boletines

* indicates required

Ingreso a Webmail

Learning To Live Magazine Revista de Salud, Bienestar y Noticias

Telephone: +1 (786) 788-2064